Monoclonal antibody αIR-3 inhibits non-small cell lung cancer growth in vitro and in vivo

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 269-275

  Zia, Farah ^a   Jacobs, Steve ^b   Kull Jr , Frederick ^b   Cuttitta, Frank ^c   Mulshine, James L ^c   Moody, Terry W ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Burroughs Wellcome Co   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

growth; IGF I; monoclonal antibodies; non small cell lung cancer; receptors

Indexed keywords

IODINE 125; MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INTERNALIZATION; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; ANIMAL; ANTIBODY SPECIFICITY; CANCER TRANSPLANTATION; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG SCREENING; IMMUNOLOGY; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PROTEIN CONFORMATION; TISSUE DISTRIBUTION; TRANSPLANTATION;

MUS MUSCULUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; IMMUNOGLOBULIN G; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTEIN CONFORMATION; RECEPTOR, IGF TYPE 1; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 34347367165     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630522     Document Type: Article

References (22)

1. Moody TW, Cuttitta F (1993): Growth factor and peptide receptors in small cell lung cancer. Life Sci 52:1161-1173.
2. Rotwein P, Folz RJ, Gordon JI (1987): Biosynthesis of human insulin-like growth factor I (IGF-I): The primary translation product of IGF-I mRNA contains an unusual 48-amino acid signal peptide. J Biol Chem 262:11807-11812.
3. Minuto F, Del Monte P, Barreca A (1986): Evidence for an increased somatomedin C/insulin-like growth factor content in primary hung lung tumors. Cancer Res 46: 985.
4. Jaques G, Rotsch M, Wegmann C, Worsch U, Maasberg M, Havemann K (1988): Production of immunoreactive insulin-like growth factor I and response to exogenous IGF-1 in small cell lung cancer cell lines. Exp Cell Res 176:336.
5. Siegfried Jill M, Kasprzk, Philip G, Treston, Anthony M, Mulshine James L, Quinn KA (1992): A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci USA 89:8107-8111.
6. Daughaday WH, Rotwein P (1989): Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrine Rev 10:68.
7. Reeve JG, Payne JA, Bleehen NM (1990): Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours. Br J Cancer 61:727.
8. Jaques G, Kiffer P, Rotsch M (1989): Production of insulin-like growth factor binding proteins by small cell lung cancer cell lines. Exp Cell Res 184:396.
9. Ullrich A, Gray A, Tam AW (1986): Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggest structural determinants that define functional specificity. EMBO 4:2503.
10. Macaulay VM, Everard MJ, Teale JD (1988): Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells. Cancer Res 50:2511.
11. Massague J, Czech MP (1982): The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem 257:5038.
12. Shigematsu K, Kataoka Y, Kamio T, Karihara M, Niwa M, Tsuchiyama H (1990): Partial characterization of insulin-like growth factor I in primary human lung cancers using immunohistochemical and receptor autoradiographic techniques. Cancer Res 50:2481.
13. Lammers R, Gray A, Schlessinger J, Ullrich A (1989): Differential signaling potential of insulin- and IGF-I receptor cytoplasmic domains. EMBO J 8:1369.
14. Nakanishi Y, Mulshine JL, Kasprzyk P, Natale R, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F (1988): Insulin-like growth factor-1 can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 82:354-359.
15. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD (1985): Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913-2923.
16. Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK (1988): Transforming growth factor B: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48:3898-3904.
17. Kull FC, Jacobs S, Su Y-F, Svoboda ME, Van Wyk JJ, Cuatrecasas P (1993): Monoclonal antibodies to receptor for insulin and somatomedin-C. J Biol Chem 258: 6561-6566.
18. Lee M, Draoui M, Zia F, Gazdar AF, Oie H, Tarr C, Bellot F, Kris R, Moody TW (1992): Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines. JNCI Monogr 13:117-123.
19. Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, Avis I, Cuttitta F, Mulshine J, Moody TW (1991): (Psi13,14) Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo. Cancer Res 51:1798-1802.
20. Arteaga Carlos L, Kitten Libbey J, Coronado Ester B, Jacobs Steven, Kull Frederick C Jr, Allred Craig D, Osborne Kent C (1989): Blockade of the type 1 somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418-1423.
21. Czech MP (1989): Signal transmission by the insulin-like growth factors. Cell 59:235.
22. Moody TW, Zia F, Draoui M, Brenneman DE, Fridkin M, Davidson A, Gozes I: Proc Natl Acad Sci USA 90: 4345-4349.